Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
K. Vasantakumar Pa
Advertisement
K. Vasantakumar Pai, PhD , is professor and chairman, PG Department of studies & research in Industrial Chemistry, Kuvempu University.
Articles by K. Vasantakumar Pa
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Advertisement
Latest Updated Articles
Review of SUT Adoption in Biopharma ManufacturingPublished: March 15th 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
2
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
3
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
4
Regulatory Challenges for Global Manufacturing of Vaccines
5
